IndraLab

Statements


USP54 activates CRC. 1 / 1
| 1

reach
"Accordingly, silencing of USP54 in colorectal cancer (CRC) cells led to a significant decrease in cell proliferation, colony formation capacity, invasiveness, and tumorigenicity in an in vivo xenograft model, indicating that USP54 could promote CRC, potentially by controlling stem cell properties in intestinal cells."